weight lossGLP-1Glucagon-like peptide-1 receptor agonists
…escribing Glucagon-like peptide-1 receptor agonists (GLP-1) for weight loss is ethically justified on grounds of autonomy, health benefit a…
Entity family
Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.
This disease is selected. Its supporting articles are shown below.
…escribing Glucagon-like peptide-1 receptor agonists (GLP-1) for weight loss is ethically justified on grounds of autonomy, health benefit a…
…Millions more Americans will now have access to GLP-1 drugs for weight loss under a new programme launched by the US government.…